SEC Form 4 · accession 0001325812-15-000015
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nishan Garabedian Christopher
Officer — President and CEO · Director
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 6:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2015 | P | 800 | $11.815 | A | 29,552 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $13.90 | Feb 27, 2015 | A | 7,196 | A | — | Feb 27, 2025 | Common Stock | 7,196 | 7,196 | D |
| Non-Qualified Stock Option (right to buy)F2 | $13.90 | Feb 27, 2015 | A | 365,804 | A | — | Feb 27, 2025 | Common Stock | 365,804 | 365,804 | D |
Explanation of responses
- F1Includes shares acquired under the Sarepta Therapeutics, Inc. 2013 Employee Stock Purchase Plan; 674 shares were acquired on August 29, 2014 at a price of $19.4905 and 800 shares were acquired on February 27, 2015.
- F225% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.